However, among younger patients (<45 years) in stages IB and II, the survival differences between sexes did not reach statistical significance ( p = 0.055 and p = 0.096, respectively) ( Figures S1–S4 ).
← all excerpts
Sex Differences in Overall Survival Among Patients with Non-Small-Cell Lung Cancer Across Clinical Stages: A Population-Based SEER Study.
1
0.0550
0.0550